Duke University Comprehensive Cancer Center

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer

Studies at this site

• Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer — Completed